These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 861135)

  • 41. Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration.
    Johnson BF; Bye C
    Br Heart J; 1975 Feb; 37(2):203-8. PubMed ID: 1091283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Digoxin prescribing in general practice 1967--77.
    Pedoe HD
    Lancet; 1978 Oct; 2(8096):931-3. PubMed ID: 81940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioavailability of digoxin tablets in healthy volunteers.
    Lee CH; Park YJ; Sands CD; Jones DW; Trang JM
    Arch Pharm Res; 1994 Apr; 17(2):80-6. PubMed ID: 10319136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Absolute bioavailability of beta-acetyldigoxin from tablets and drops in healthy subjects].
    Dreyer M; Dammann HG; Endell W; Rudolph M; Iven H
    Arzneimittelforschung; 1992 Mar; 42(3):303-6. PubMed ID: 1497688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of dose on bioavailability of oral digoxin.
    Ochs HR; Bodem G; Greenblatt DJ
    Eur J Clin Pharmacol; 1981 Jan; 19(1):53-5. PubMed ID: 7461024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioavailability of digoxin from rapidly dissolving preparations.
    Johnson BF; Lader S
    Br J Clin Pharmacol; 1974 Aug; 1(4):329-33. PubMed ID: 22454888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absolute bioavailability of digoxin tablets.
    Beveridge T; Nüesch E; Ohnhaus EE
    Arzneimittelforschung; 1978; 28(4):701-3. PubMed ID: 581950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers.
    Bansinath M; Ghosh SS; Shafiqa A; Shukla VK; Chopra KS; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):30-3. PubMed ID: 3957487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of a standard breakfast on digoxin absorption in normal subjects.
    Johnson BF; O'Grady J; Sabey GA; Bye C
    Clin Pharmacol Ther; 1978 Mar; 23(3):315-9. PubMed ID: 627138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation.
    Bochner F; Huffman DH; Shen DD; Azarnoff DL
    J Pharm Sci; 1977 May; 66(5):644-7. PubMed ID: 874745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Letter: Improving the bioavailability of digoxin.
    Binnion PF; Klopp RW
    Lancet; 1975 Jun; 1(7922):1422-3. PubMed ID: 49581
    [No Abstract]   [Full Text] [Related]  

  • 52. Lanoxicaps: a new digoxin formulation with improved bioavailability.
    Brown D
    Iowa Med; 1984 Jul; 74(7):303-4. PubMed ID: 6746244
    [No Abstract]   [Full Text] [Related]  

  • 53. The effects of some organic solvents on the absorption of digoxin by man.
    Fowle AS; French J; O'Grady J
    Arzneimittelforschung; 1981; 31(6):1029-31. PubMed ID: 7196235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of methodology in single-dose studies of digoxin bioavailability.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    Pharmacology; 1976; 14(2):182-90. PubMed ID: 959319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Digoxin tablet bioavailability: single-dose and steady-state assessment.
    Preibisz JJ; Butler VP; Lindenbaum J
    Ann Intern Med; 1974 Oct; 81(4):469-74. PubMed ID: 4412826
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.
    Wagner JG; Stoll RG; Weidler DJ; Ayres JW; Hallmark MR; Sakmar E; Yacobi A
    J Pharmacokinet Biopharm; 1979 Apr; 7(2):147-58. PubMed ID: 20218011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment.
    Okada RD; Hager WD; Graves PE; Mayersohn M; Perrier DG; Marcus FI
    Circulation; 1978 Dec; 58(6):1196-203. PubMed ID: 709776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioavailability of different lots of digoxin tablets from the same manufacturer.
    Lindenbaum J
    Clin Pharmacol Ther; 1975 Mar; 17(3):296-301. PubMed ID: 1091397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum levels of digoxin administered in soft gelatin capsules and tablets and evaluated by both radioimmunoassay and enzyme immunoassay.
    Nicaise J; Molron D; Gandolfi C; Ghirardi P; Marzo A
    Farmaco Prat; 1981 Jul; 36(7):341-6. PubMed ID: 7023968
    [No Abstract]   [Full Text] [Related]  

  • 60. [Comparison of digitoxin bioavailability from tablets and elixir during maintenance therapy (author's transl)].
    Ochs H; Bodem G; Hahn E; Dengler HJ
    Klin Wochenschr; 1975 May; 53(9):425-9. PubMed ID: 1152354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.